Rapport Therapeutics, Inc. - 8-K Filing
Rapport Therapeutics raises approximately $382.5 million through combined common stock offering and $172.5 million convertible senior notes issuance. (Items: 1.01 Entry into a Material Definitive Agreement, 2.02 Results of Operations and Financial Condition, 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, 3.02 Unregistered Sales of Equity Securities)
Tickers: $RAPP